These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10942038)

  • 1. Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies.
    Fratiglioni L; Wang HX
    Behav Brain Res; 2000 Aug; 113(1-2):117-20. PubMed ID: 10942038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of cigarette smoking.
    Chang RC; Ho YS; Wong S; Gentleman SM; Ng HK
    Acta Neuropathol; 2014 Jan; 127(1):53-69. PubMed ID: 24240736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "protective" influence of cigarette smoking on Alzheimer's and Parkinson's diseases. Quagmire or opportunity for neuroepidemiology?
    Riggs JE
    Neurol Clin; 1996 May; 14(2):353-8. PubMed ID: 8827176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease.
    Fritz NE; Kegelmeyer DA; Kloos AD; Linder S; Park A; Kataki M; Adeli A; Agrawal P; Scharre DW; Kostyk SK
    Gait Posture; 2016 Oct; 50():1-7. PubMed ID: 27544062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
    Braak H; Braak E; Yilmazer D; de Vos RA; Jansen EN; Bohl J
    J Neural Transm (Vienna); 1996; 103(4):455-90. PubMed ID: 9617789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cigarette smoking and Parkinson's disease: a population based case-control study].
    Dong JQ; Zhang QH; Jiang ZX; Yi ZY; Yu L; Li ZH; Zhang YQ; Fang MJ; Zhang ZX; Zhang KL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):604-7. PubMed ID: 12975019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's and Alzheimer's diseases: epidemiological comparison. 1. Descriptive aspects.
    Treves TA; Chandra V; Korczyn AD
    Neuroepidemiology; 1993; 12(6):336-44. PubMed ID: 8309509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.
    Jabir NR; Firoz CK; Baeesa SS; Ashraf GM; Akhtar S; Kamal W; Kamal MA; Tabrez S
    CNS Neurosci Ther; 2015 Jan; 21(1):1-7. PubMed ID: 25399848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases.
    McKenzie JA; Spielman LJ; Pointer CB; Lowry JR; Bajwa E; Lee CW; Klegeris A
    Curr Aging Sci; 2017; 10(3):158-176. PubMed ID: 28302047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
    Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
    Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
    Calne DB; Eisen A
    Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality from Alzheimer's disease, Parkinson's disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach.
    Désesquelles A; Demuru E; Salvatore MA; Pappagallo M; Frova L; Meslé F; Egidi V
    J Aging Health; 2014 Mar; 26(2):283-315. PubMed ID: 24667337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum phosphate concentration as the result of smoking might underlie the lower risk of Parkinson's disease.
    Håglin L
    Med Hypotheses; 2015 Sep; 85(3):287-90. PubMed ID: 26206759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease.
    Jellinger KA; Seppi K; Wenning GK; Poewe W
    J Neural Transm (Vienna); 2002 Mar; 109(3):329-39. PubMed ID: 11956955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
    Eggers AE
    Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease and smoking: an integral part of PD's etiological study.
    Dong JQ; Zhang ZX; Zhang KL
    Biomed Environ Sci; 2003 Jun; 16(2):173-9. PubMed ID: 12964791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting-state networks in Alzheimer's disease and Parkinson's disease.
    Rektorova I
    Neurodegener Dis; 2014; 13(2-3):186-8. PubMed ID: 24008996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural evidence for defective top-down control of visual processing in Parkinson's and Alzheimer's disease.
    Nemcova Elfmarkova N; Gajdos M; Rektorova I; Marecek R; Rapcsak SZ
    Neuropsychologia; 2017 Nov; 106():236-244. PubMed ID: 28974380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.
    Durazzo TC; Mattsson N; Weiner MW;
    Alzheimers Dement; 2014 Jun; 10(3 Suppl):S122-45. PubMed ID: 24924665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.